loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

List of Certificates of Suitability (CEPs) for cep_2023_213___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Ajinomoto Co., Inc. Tokyo JP (1)

filter

01 Histidine Hydrochloride Monohydrate, SA (1)

filter

01 Japan (1)

filter

01 Valid (1)

Histidine Hydrochloride Monohydrate, SA

URL Supplier Web Content
CEP 2023-213 - Rev 00
Valid
Chemical
2024-03-04
910
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for CEP 2023-213 - Rev 00 of Ajinomoto Co., Inc. Tokyo Jp

Looking for Certificates of Suitability (CEPs) for CEP 2023-213 - Rev 00 of Ajinomoto Co., Inc. Tokyo Jp 1

20

Ajinomoto Co., Inc. Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Histidine Hydrochloride Monohydrate, SA, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-213 - Rev 00

This Chemical Type CEP, issued on March 04, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 910 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY